免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

HemoSphere先進監控平台,HemoSphere ClearSight 模組

K 號:K201446 · 2020-10-01

決定日期2020-10-01
產品代碼DQK
諮詢委員會履歷
決定相當於

器材摘要

HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module is the device name listed in this FDA 510(k) record. The listed applicant is Edwards Lifesiences, LLC. It received FDA 510(k) clearance on 2020-10-01 under 510(k) number K201446. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module?

HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module is a medical device that received FDA 510(k) clearance on 2020-10-01. The listed applicant is Edwards Lifesiences, LLC. The 510(k) number is K201446.

When did HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module receive FDA 510(k) clearance?

HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module received FDA 510(k) clearance on 2020-10-01, under 510(k) number K201446.

Who is the listed applicant for HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module?

The FDA 510(k) record lists Edwards Lifesiences, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module?

The FDA product code for HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module is DQK.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Edwards Lifesiences, LLC 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DQK)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑